Do People With a Certain Blood Type Really Have a Higher Chance of Living to 100? A Deep Dive Into the Science of Blood Groups and Longevity
Every year, scientists uncover more details about what helps some people live far longer than others. Some people reach age 100 — becoming centenarians — and even older. For decades, researchers have asked whether genetic factors like blood type might influence extreme longevity. Recently, some articles claimed that individuals with a specific blood type are more likely to live to 100. But what do real studies actually show, what mechanisms might be involved, and how much can blood type alone tell us about your chances of becoming a centenarian?
The short answer? There’s no definitive evidence that a single blood type guarantees a greater chance of living to 100. The research is complicated, often conflicting, and influenced by many other biological and lifestyle factors. But it is an interesting area of scientific inquiry — one that tells us more about aging biology and population health. In this article, we’ll explore the science behind blood types and longevity, what studies have found (and where they disagree), and what really matters for a long, healthy life.
What Are Blood Types and Why Might They Matter?
To understand why scientists have studied blood type and longevity, it’s helpful to know what blood types are. The most commonly discussed system is the ABO blood group — which divides people into four main types:
- Type A
- Type B
- Type AB
- Type O
These categories are based on specific sugar molecules (antigens) present on the surface of red blood cells, with the presence or absence of these antigens determining your type. There’s also the Rh factor (positive or negative), but most longevity studies focus on the ABO system.
Blood type matters medically — especially in transfusion compatibility — but it also influences levels of certain proteins in the body. For example, individuals with blood type O typically have lower levels of von Willebrand factor and factor VIII compared with those with non‑O blood types. These proteins are part of the clotting system and impact the risk of thrombotic (clot‑related) diseases.
Because of these biological differences, researchers have hypothesized that blood type could influence disease risk in ways that might affect lifespan — and perhaps longevity.
Early Studies on Blood Type and Survival
The idea that blood type might influence longevity has been around for many decades. Some of the earliest research dates back to the mid‑20th century. For instance:
- One small study from 1961 observed a higher proportion of blood type A among older men (~65–89 years) compared with younger controls.
- Later research in the 1970s suggested that individuals with blood type O were more common among those older than 75.
- In 2004, a study in Tokyo reported that blood type B appeared more frequently among a group of centenarians compared with regional controls, hinting at a possible longevity link.
However, these early studies were often small, region‑specific, or limited by their design. Many didn’t account for other important factors like health behaviors, socioeconomic status, or background disease risk — making their conclusions hard to generalize.
More Recent and Larger Research: Mixed Findings
In the last decade, larger and more systematic analyses sought to examine the association between blood type and longevity more rigorously. Some key findings include:
1. No Clear, Consistent Link Between ABO Blood Type and Longevity
A retrospective analysis of hundreds of deaths at a U.S. hospital found that blood type B was actually less common in older age groups and did not appear to be a marker of longevity. In that population, people with blood type B had worse survival curves than other types.
Similarly, a comprehensive review of ABO blood group distribution across age groups found no clear, consistent association linking any single blood type to extended lifespan across all populations. Some studies show small differences in frequency, but the results are inconsistent and vary by region and sample.
2. Some Populations Show Differences in Frequencies
In certain localized studies — for example, centenarians in Tokyo — researchers did observe a higher proportion of individuals with blood type B among those who lived beyond age 100. But these findings weren’t replicated in all populations or across diverse geographic groups.
This suggests that population genetics, ethnic background, and local environmental factors play a large role — potentially confounding the link between blood type and longevity.
Why the Results Are Conflicting
Why do different studies reach different conclusions? There are several reasons:
Population Differences
Blood type distributions vary around the world. Certain blood groups are more common in some ethnic or regional populations than others. This means a blood type that appears common among centenarians in one region might merely reflect broader population patterns rather than a biological longevity advantage.
Sample and Methodological Limitations
Many studies are small, retrospective, or based on hospital or registry records that don’t capture lifestyle or environmental factors. Those confounding factors — such as diet, smoking, physical activity, and access to healthcare — have powerful effects on lifespan independent of blood type.
Causation vs. Correlation
Even if a certain blood type appears more often among long‑lived individuals in a study, this doesn’t prove causation. A higher frequency might simply reflect demographic factors or statistical noise rather than a true biological advantage.
When Blood Type Might Relate to Longevity: A Biological Perspective
While the evidence does not support a simple claim like “Blood type X guarantees a longer life,” blood type can influence risk factors that affect health outcomes — and those outcomes, in turn, influence lifespan.
For example:
Heart Disease and Stroke Risk
Several studies suggest that individuals with blood type O have a lower risk of heart attacks and strokes compared with non‑O types. These conditions are major causes of death worldwide, and lower risk could theoretically contribute to longer life expectancy.
Cancer Risk
Blood type may also influence the risk of certain cancers. For instance, some research shows people with non‑O blood types have slightly higher risks for pancreatic or gastric cancers — diseases that tend to occur in mid‑ to late life. Reducing risk of such diseases could positively affect lifespan.
However, the effects are modest and are likely only one of many genetic and environmental factors contributing to disease susceptibility. Blood type alone is not a strong or reliable predictor of health outcomes on its own.
Broader Blood Biomarkers & Longevity
Interestingly, a large and well‑designed study from Sweden did examine blood markers in relation to longevity, though not solely focusing on ABO blood type. Researchers followed more than 44,000 adults for up to 35 years, tracking who lived to age 100 and who did not, and compared common blood biomarkers taken decades earlier.
Key findings from this research include:
- Individuals who lived to 100 tended to have lower levels of glucose, creatinine, and uric acid from their 60s onward, compared with their shorter‑lived peers.
- Very low levels of total cholesterol or iron were associated with lower chances of reaching 100, indicating that extreme deficiencies may be detrimental.
- The research focused on overall blood profiles — not just ABO type — suggesting that a combination of metabolic and organ function markers relates more closely to longevity than blood group alone.
This finding highlights an important point: biomarkers of overall health status are more predictive of reaching extreme age than a single genetic trait like blood type.
So, Is There a “Longevity Blood Type”?
Based on available evidence from diverse studies, the answer is: no single blood type has been conclusively proven to increase the likelihood of living to 100. The research is inconsistent, and any observed differences are generally small, population‑specific, and influenced by many other factors.
While some studies report associations — for example, more individuals with blood type B among centenarians in a small Japanese cohort — others find no significant link or even opposite trends in different populations.
Many scientists conclude that if any link between ABO blood group and longevity exists, it’s likely indirect and context‑dependent: mediated through disease risks, environmental factors, lifestyle habits, and genetic background.
What Else Matters More for Longevity
Scientists agree that blood type is just one tiny piece of the longevity puzzle. Here are factors that have a far bigger impact on the odds of living to — and beyond — 100:
1. Genetics Beyond ABO
Many genes influence aging processes, immune function, and disease resistance. Rare genetic variants have been identified in long‑lived populations like centenarians.
2. Lifestyle Habits
Diet quality, physical activity, sleep, smoking status, and stress levels are powerful predictors of health and lifespan. These factors shape blood glucose, cholesterol, inflammation markers, and more — much more significantly than blood type alone.
3. Access to Healthcare
Preventive care, early disease detection, and effective chronic disease management can dramatically improve life expectancy.
4. Socioeconomic Factors
Education, income, and community resources influence health outcomes throughout life, often more than genetic markers like blood type.
5. Metabolic and Organ Health
Blood biomarker profiles (like those tracked in the Swedish study) that reflect how well your body processes glucose, maintains kidney and liver function, and balances inflammation are much closer reflections of biological aging.
Conclusion: What Science Really Says About Blood Type and Living to 100
The idea that a particular blood type could guarantee a higher chance of living to 100 is appealing, but the science doesn’t support that simplistic claim. Current evidence shows:
- There’s no universally agreed‑upon “longevity blood type.”
- Some blood types might be associated with lower risks of specific diseases like heart disease or stroke, which may indirectly support longer life — but these effects are small.
- Large, well‑designed studies point to broader blood biomarker profiles — including glucose, uric acid, creatinine, and others — as better predictors of exceptional longevity.
- Longevity is influenced by a complex combination of genetics, metabolism, lifestyle behaviors, healthcare access, and environment — far beyond blood type alone.
In short, your blood type may be one piece of your biological profile, but it’s not the defining factor in whether you live to 100. What you eat, how active you are, your medical care, and how you manage risk factors like blood sugar and cardiovascular health matter far more. Understanding the science behind longevity can help you make informed choices — but no single test or trait can fully predict your lifespan.
